Trials / Not Yet Recruiting
Not Yet RecruitingNCT07152873
A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A
An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Safety and the Pharmacokinetics of AD-117 Compared to AD-117A in Healthy Adult Volunteers Under Fed State Conditions
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Addpharma Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-117 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AD-117 | AD-117 1Tab., Per Oral |
| DRUG | AD-117A | AD-117A 1Tab., Per Oral |
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2026-02-01
- Completion
- 2026-03-01
- First posted
- 2025-09-03
- Last updated
- 2025-12-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07152873. Inclusion in this directory is not an endorsement.